Author: healthylife7

A newly published study explores an understudied recreational inhalant and its connection to sexual health, while showcasing how faculty and student collaboration advances meaningful public health research

An ongoing food safety investigation into the potentials implicated a produce supplier for the second time in recent weeks

This is a paid press release. Contact the press release distributor directly with any inquiries.

GO! St. Louis is proving race season doesn’t end with the marathon. This year its new summer lineup included trail relays, family-friendly fun runs, and relaxed evening races that welcomed everyone from first-time runners to seasoned competitors, all while building community through movement

– Planned acquisition leverages existing regulatory and commercial infrastructure and leadership’s experience in Fabry therapy commercialization –

U.S. News & World Report, a global leader in healthcare decision support, has unveiled its inaugural Best GLP-1 Telehealth Platforms ratings. The new rankings assess 20 online providers offering FDA-approved, brand-name GLP-1 medications, including Wegovy, Zepbound, Ozempic and Foundayo, helping consumers make informed choices in the growing digital weight management market

This work, 86th Training Division Warrior Exercise Team 2026, by MAJ Jon Dahl, identified by DVIDS, must comply with the restrictions shown on https://www.dvidshub.net/about/copyright

For patients facing serious illnesses, access to cutting-edge, innovative treatments can make all the difference. Historically, many Nevadans have looked outside the state to participate in clinical trials or benefit from the latest medical discoveries. Today, access is coming closer to home. 

​Droga5 Dublin, part of Accenture Song, has partnered with Lidl Ireland and Cork youth collective Kabin Crew to launch a new campaign designed to inspire children across Ireland to engage with healthier eating habits and discover the benefits of fruit and vegetables

Kailera Therapeutics, Inc. reported results for the quarter ended 2Q 2026 showing no product or other revenue and a widened net loss. The company recorded a net loss attributable to common stockholders of $(111.3M) versus a net loss of $(28.9M) in the year‑ago quarter, with basic and diluted loss per share of $(1.09) for 2Q…